BLCM
Price:
$0.07475
Market Cap:
$778.33K
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an ...[Read more]
Industry
Biotechnology
IPO Date
2014-12-18
Stock Exchange
NASDAQ
Ticker
BLCM
According to Bellicum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.04. This represents a change of -21.48% compared to the average of 3.88 of the last 4 quarters.
The mean historical Current Ratio of Bellicum Pharmaceuticals, Inc. over the last ten years is 10.95. The current 3.04 Current Ratio has changed 2.68% with respect to the historical average. Over the past ten years (40 quarters), BLCM's Current Ratio was at its highest in in the March 2015 quarter at 69.87. The Current Ratio was at its lowest in in the March 2014 quarter at 0.
Average
10.95
Median
6.65
Minimum
1.18
Maximum
53.14
Discovering the peaks and valleys of Bellicum Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 862.81%
Maximum Annual Current Ratio = 53.14
Minimum Annual Increase = -80.35%
Minimum Annual Current Ratio = 1.18
Year | Current Ratio | Change |
---|---|---|
2022 | 6.31 | -13.80% |
2021 | 7.32 | 358.40% |
2020 | 1.60 | 34.79% |
2019 | 1.18 | -80.35% |
2018 | 6.03 | -27.89% |
2017 | 8.36 | 19.66% |
2016 | 6.99 | -46.30% |
2015 | 13.01 | -75.51% |
2014 | 53.14 | 862.81% |
2013 | 5.52 | 394.97% |
The current Current Ratio of Bellicum Pharmaceuticals, Inc. (BLCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.08
5-year avg
4.49
10-year avg
10.95
Bellicum Pharmaceuticals, Inc.’s Current Ratio is greater than Cellectis S.A. (1.78), less than Adaptimmune Therapeutics plc (3.85), less than Calithera Biosciences, Inc. (3.60), greater than Atara Biotherapeutics, Inc. (0.59), greater than Affimed N.V. (1.93),
Company | Current Ratio | Market cap |
---|---|---|
1.78 | $112.47M | |
3.85 | $148.11M | |
3.60 | $487.00 | |
0.59 | $76.78M | |
1.93 | $18.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellicum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bellicum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Bellicum Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Bellicum Pharmaceuticals, Inc. (BLCM)?
What is the highest Current Ratio for Bellicum Pharmaceuticals, Inc. (BLCM)?
What is the 3-year average Current Ratio for Bellicum Pharmaceuticals, Inc. (BLCM)?
What is the 5-year average Current Ratio for Bellicum Pharmaceuticals, Inc. (BLCM)?
How does the current Current Ratio for Bellicum Pharmaceuticals, Inc. (BLCM) compare to its historical average?